What are the epileptic encephalopathies?
Journal
Current opinion in neurology
ISSN: 1473-6551
Titre abrégé: Curr Opin Neurol
Pays: England
ID NLM: 9319162
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
13
2
2020
medline:
23
1
2021
entrez:
13
2
2020
Statut:
ppublish
Résumé
To review the evolution of the concept of epileptic encephalopathy during the course of past years and analyze how the current definition might impact on both clinical practice and research. Developmental delay in children with epilepsy could be the expression of the cause, consequence of intense epileptiform activity (seizures and EEG abnormalities), or because of the combination of both factors. Therefore, the current International League Against Epilepsy classification identified three electroclinical entities that are those of developmental encephalopathy, epileptic encephalopathy, and developmental and epileptic encephalopathy (DEE). Many biological pathways could be involved in the pathogenesis of DEEs. DNA repair, transcriptional regulation, axon myelination, metabolite and ion transport, and peroxisomal function could all be involved in DEE. Also, epilepsy and epileptiform discharges might impact on cognition via several mechanisms, although they are not fully understood. The correct and early identification of cause in DEE might increase the chances of a targeted treatment regimen. Interfering with neurobiological processes of the disease will be the most successful way in order to improve both the cognitive disturbances and epilepsy that are the key features of DEE.
Identifiants
pubmed: 32049741
doi: 10.1097/WCO.0000000000000793
pii: 00019052-202004000-00005
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-184Références
Dulac O. Epileptic encephalopathies. Epilepsia 2001; 42: (Suppl 3): 23–26.
Scheffer IE, French J, Hirsch E, et al. Classification of the epilepsies: new concepts for discussion and debate-special report of the ILAE Classification Task Force of the Commission for Classification and Terminology. Epilepsia Open 2016; 21:37–44.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58:512–521.
Gastaut H, Roger J, Ouahchi S, et al. An electroclinical study of generalized epileptic seizures of tonic expression. Epilepsia 1963; 4:15–44.
Landau WM, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder in children. Neurology 1957; 7:523–530.
Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42:1–8.
Engel J Jr. Report of the ILAE Classification Core Group. Epilepsia 2006; 47:1558–1568.
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010; 51:676–685.
Ohtahara S, Ishida T, Oka E, Inoue H. On the specific age- dependent epileptic syndromes: the early-infantile epileptic encephalopathy with suppression-burst. No To Hattatsu 1976; 8:270–280.
Ohtahara S, Yamatogi Y. Pellock JM, Bourgeois B, Dodson WE. Severe encephalopathic epilepsy in early infancy. Pediatric epilepsy. New York: Demos; 2008. 241–247.
Berg, Langfitt AT, Testa JTFM, et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia 2008; 49:608–614.
Myers KA, Johnstone DL, Dyment DA. Epilepsy genetics: current knowledge, applications, and future directions. Clin Genet 2019; 95:95–111.
Martin MS, Dutt K, Papale LA, et al. Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem 2010; 285:9823–9834.
Ragona F, Granata T, Dalla Bernardina B, et al. Cognitive development in Dravet syndrome: a retrospective, multicenterstudy of 26 patients. Epilepsia 2011; 52:386–392.
Villeneuve N, Laguitton V, Viellard M, et al. Cognitive and adaptive evaluation of 21 consecutive patients with Dravet syndrome. Epilepsy Behav 2014; 31:143–148.
Ouss L, Leunen D, Laschet J, et al. Autism spectrum disorder and cognitive profile in children with Dravet syndrome: delineation of a specific phenotype. Epilepsia Open 2018; 20:40–53.
Dravet C, Bureau M, Oguni H. Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolff P, et al. Severe myoclonic epilepsy in infancy (Dravet syndrome). Epileptic syn- dromes in infancy, childhood and adolescence 4th edn.France: John Libbey Eurotext; 2005. 89–113.
Catterall WA, Kalume F, Oakley JC. NaV1.1 channels and epilepsy. J Physiol 2010; 588:1849–1859.
Kelley SA, Knupp KG. Infantile spasms-have we made progress? Curr Neurol Neurosci Rep 2018; 18:27.
Nabbout R, Andrade DM, Bahi-Buisson N, et al. Outcome of childhood-onset epilepsy from adolescence to adulthood: transition issues. Epilepsy Behav 2017; 69:161–169.
Pal DK, Ferrie C, Addis L, et al. Idiopathic focal epilepsies: the ‘lost tribe’. Epileptic Disord 2016; 18:252–288.
Tibussek D, Klepper J, Korinthenberg R, et al. Treatment of infantile spasms: report of the Interdisciplinary Guideline Committee Coordinated by the German-Speaking Society for Neuropediatrics. Neuropediatrics 2016; 47:139–150.
Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012; 44:941–945.
Lim JS, Gopalappa R, Kim SH, et al. Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia. Am J Hum Genet 2017; 100:454–472.
Ribierre T, Deleuze C, Bacq A, et al. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. J Clin Invest 2018; 128:2452–2458.
Mefford HC, Yendle SC, Hsu C, et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol 2011; 70:974–985.
Wei F, Yan LM, Su T, et al. Ion channel genes and epilepsy: functional alteration, pathogenic potential, and mechanism of epilepsy. Neurosci Bull 2017; 33:455–477.
He N, Lin ZJ, Wang J, et al. Evaluating the pathogenic potential of genes with de novo variants in epileptic encephalopathies. Genet Med 2019; 21:17–27.
McTague A, Howell KB, Cross JH, et al. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol 2016; 15:304–316.
Cilio MR, Sogawa Y, Cha BH, et al. Long-term effects of status epilepticus in the immature brain are specific for age and model. Epilepsia 2003; 44:518–528.
Holmes GL. Effect of Seizures on the Developing Brain and, Cognition. Semin Pediatr Neurol 2016; 23:120–126.
Rigas P, Sigalas C, Nikita M, et al. Long-term effects of early life seizures on endogenous local network activity of the mouse neocortex. Front Synaptic Neurosci 2018; 10:43.
Siniatchkin M, van Baalen A, Jacobs J, et al. Different neuronal networks are associated with spikes and slow activity in hypsarrhythmia. Epilepsia 2007; 48:2312–2321.
Japaridze N, Muthuraman M, Moeller F, et al. Neuronal networks in west syndrome as revealed by source analysis and renormalized partial directed coherence. Brain Topogr 2013; 26:157–170.
Siniatchkin M, Coropceanu D, Moeller F, et al. EEG-fMRI reveals activation of brainstem and thalamus in patients with Lennox-Gastaut syndrome. Epilepsia 2011; 52:766–774.
Archer JS, Warren AE, Jackson GD, Abbott DF. Conceptualizing Lennox-Gastaut syndrome as a secondary network epilepsy. Front Neurol 2014; 5:225.
Japaridze N, Muthuraman M, Dierck C, et al. Neuronal networks in epileptic encephalopathies with CSWS. Epilepsia 2017; 57:1245–1255.
Vigevano F, Arzimanoglou A, Plouin P, Specchio N. Therapeutic approach to epileptic encephalopathies. Epilepsia 2013; 54: (Suppl 8): 45–50.
Specchio N, Trivisano M, Scott RC, Ferrie C. Epileptic encephalopathy. Epilepsy Res Treat 2012. 460256.